Investment in Technology for Real-World Evidence to Double by 2025
IDC FutureScape: Worldwide Life Sciences 2022 Predictions
Leveraging real-world data to generate evidence is crucial when developing safe and effective treatments. But these data are as complicated as they are necessary. With multiple data owners, varied sources, and a vast range of quality and completeness, it is essential to make use of technology to ensure data utility.
A recent report from IDC provides IT and business executives across the globe with actionable insights into key trends shaping the future of the life sciences industry. The report offers 10 predictions exploring several key themes, including:
- Data liquidity and real-world evidence
- Artificial intelligence/machine learning and extended reality
- Disaggregated care models, "patient centricity," and engagement
According to Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights, "the 2022 worldwide life sciences industry predictions focus upon how the life sciences industry is embedding innovative technologies and data centricity across the value chain, helping it transition beyond the disruption caused by the pandemic to agile, 'patient centric' business models with a focus on digital resiliency and accelerated growth."